YEA CHRISTOPHER (Chief Development Officer) sold 0.8% of their position (1.97K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $52.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/27/2026ACC: 0001691102-26-000006
Officer· Chief Development Officer
Since Sep 2018
-1.97K
Net shares
Net seller
$52.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.13K acquired · 5.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.13K
Price / share
—
Trade value
—
% of position
1.4%
5/22/2026
228.76K→231.88K
Common Stock
Direct
Shares
−1.97K
Price / share
$26.78
Trade value
$52.65K
% of position
0.8%
5/26/2026
231.88K→229.92K
Total
Net shares
+1.16K
Net value
-$52.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/22/2026 | M · Option Exercise | +3.13K | — | — | 1.4% | 228.76K | 231.88K |
| Common Stock Direct | 5/26/2026 | S · Sale | −1.97K | $26.78 | $52.65K | 0.8% | 231.88K | 229.92K |
| Total | +1.16K | -$52.65K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
3.13K shares
Shares
−3.13K
Strike price
Held after
25K
Exercisable
—
5/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock3.13K shares | 5/22/2026 | M · Option Exercise | −3.13K | — | 25K |